Understanding clinician support preferences related to the use of pharmacogenomic results in electronic health records: A qualitative study in an academic health system
Clinician-preferred strategies, including intuitive clinical decision support tools, modular education resources, and streamlined communication pathways, are critical to successful PGx implementation. These findings offer a practical blueprint for integrating PGx into clinical practice and inform scalable models for precision medicine adoption across health systems. Further research should explore nuanced themes to further accelerate PGx deployments.
Authors
- Lucas A. Berenbrok (ORCID: https://orcid.org/0000-0001-9479-8209)
- Philip E. Empey (ORCID: https://orcid.org/0000-0001-7474-2339)
- Mylynda Massart (ORCID: https://orcid.org/0000-0002-8835-7957)
- Erika Dreikorn
- Simona Sacchi (ORCID: https://orcid.org/0000-0003-2433-7153)
- Katherine Riden
Institutions
- University of Pittsburgh (US)
- UPMC Health System (US)
- University of Pittsburgh Medical Center (US)
- PharmacoGenetics (China) (CN)
Publication Details
- Journal
- Journal of the American Pharmacists Association
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1016/j.japh.2025.102912
- Citations
- 2
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 3.11